Heart surgery study tests new material for closing the Heart's protective sac
NCT ID NCT06136182
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two materials, Gentrix and CorMatrix, used to close the pericardium (the sac around the heart) after heart surgery. Researchers looked at how long patients stayed in the hospital and whether they were readmitted within 30 days. The trial was terminated early, so the findings are incomplete.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Gentrix (a material used to close the sac around the heart after surgery)
- What this could lead to
- If successful, Gentrix could offer an alternative to CorMatrix for closing the pericardium after heart surgery, potentially reducing complications like fluid buildup.
- What could go wrong
- The trial was terminated early, so results are limited. It is unclear if Gentrix is better or safer than the standard option.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL OUTCOME OF PERICARDIAL CLOSURE USING GENTRIX are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Institute at Methodist Health System
Dallas, Texas, 75203, United States
-
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States